Neoadjuvant treatment was also linked to a general reduction in tumor cell proliferation, as determined by IHC analysis of ki67, in the absence of senescence traits such as enlarged nuclei (Supplementary Table S2) or high p16 levels (Fig. S4B). Here, MKI67 is linked to neoplasm.